From Lab Coats To Lycra - Australian Melanoma experts take on world Triathlon championships

2 September 2019
They are a formidable team - in work and in play
Co-Medical Directors of Melanoma Institute Australia, Professor Georgina Long and Professor Richard Scolyer, and melanoma pathologist Dr
This high achieving trio swapped their lab coats for lycra as they represented Australia in the green and gold.
All three qualified for the Australian Triathlon Team in their respective age
• Professor Georgina Long, 45-49 Female AG Sprint
• Professor Richard Scolyer, 50-54 Male AG Sprint
• Dr
Each week, they collectively swim
Whilst au fait in sharing the stage at international melanoma and oncology conferences, this was their first time as teammates on the international sporting stage.
As Co-Medical Directors of Melanoma Institute Australia, Professor Long and Professor Scolyer

World Congress on Cancers of the Skin 2018
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.

Melanoma Institute Australia welcomes new CEO Matthew Browne
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).

Melanoma in Practice: Nurse Conference
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.

Reducing the risk of melanoma in young adults
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.

Melanoma Institute Australia launches free e-learning education portal
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.

David Day and a lifetime of missed moments
When David lost his life last year, he was 33, with three daughters under six.

ASCO 2018 – the important role of clinical trials
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.

MIA Scoops Awards at the International Academy of Pathology
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.

Updated Clinical Guidelines for Melanoma
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.

Melanoma and Marital Status: A Study
An American study has discovered a link between early detection and marital status in melanoma diagnosis.

A weekend in Paris talking all things pathology...
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.

Our own 'Australian Story'
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.

Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.

The inspiring story of Emma Betts premieres on Australian Story
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.

Toyota helps tackle Australia's national cancer - melanoma
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.

Tackling the Kokoda Trail for melanoma
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.

Professor Richard Scolyer presents at world's largest annual meeting of pathologists
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.

Farewell from Carole Renouf, CEO of Melanoma Institute Australia
A message from our CEO, Carole Renouf